The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Project IOTA (input optimization for tissue-based assays): Improving turnaround time (TAT) of mutation profiling for non-small cell lung cancer (NSCLC).
 
Tripti Jain
No Relationships to Disclose
 
Han Yu
No Relationships to Disclose
 
Sean Glenn
No Relationships to Disclose
 
Michael Petroziello
No Relationships to Disclose
 
Nathaniel Ivanick
No Relationships to Disclose
 
Blake Burgher
No Relationships to Disclose
 
Carl Morrison
Employment - OmniSeq
Consulting or Advisory Role - OmniSeq; Thermo Fisher Scientific
Patents, Royalties, Other Intellectual Property - OmniSeq (Inst)
 
Saraswati Pokharel
No Relationships to Disclose
 
Grace Dy
Consulting or Advisory Role - AADi; Amgen; AstraZeneca; Bayer; Bristol Myers Squibb Foundation; Novartis; Whitehawk Therapeutics
Research Funding - AMGEN (Inst); AstraZeneca (Inst); Bioatla (Inst); Lilly (Inst); Mirati Therapeutics (Inst); Revolution Medicines (Inst); Zai Lab (Inst)
Patents, Royalties, Other Intellectual Property - Patent pending for exosomal-based assay for cancer detection, diagnosis and therapy